Working… Menu

Pilot Study for Automated Deep Brain Stimulation Programming

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02046863
Recruitment Status : Completed
First Posted : January 28, 2014
Results First Posted : August 9, 2016
Last Update Posted : September 22, 2016
National Institute of Neurological Disorders and Stroke (NINDS)
University of Cincinnati
Information provided by (Responsible Party):
Great Lakes NeuroTechnologies Inc.

Brief Summary:
The clinical utility of deep brain stimulation (DBS) for the treatment of movement disorders such as Parkinson's disease has been well established; however, there is a great disparity in outcomes among DBS recipients due to varied postoperative management, particularly concerning the choosing of an optimal set of programming parameters from the thousands of possible combinations. This study will evaluate the use of motion sensor based assessments to develop a functional map and algorithms to automatically determine a set of programming parameters that maximize symptomatic benefits while minimizing side effects and battery consumption.

Condition or disease Intervention/treatment Phase
Parkinson's Disease Tremor Bradykinesia Device: Automated Programming Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 7 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I
Study Start Date : November 2013
Actual Primary Completion Date : August 2014
Actual Study Completion Date : August 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tremor

Arm Intervention/treatment
Experimental: Automated Programming
Subjects will have DBS settings changed as guided by prototype DBS-Expert software. Tremor, bradykinesia, and dyskinesia will be assessed at each DBS setting.
Device: Automated Programming
Prototype DBS-Expert software will be used to guide a clinician through DBS programming.

Primary Outcome Measures :
  1. Percent Change From Baseline in Kinesia HomeView Symptom Ratings After Guided DBS Programming [ Time Frame: Within two days of standard clinical DBS programming session ]
    Symptoms were first assessed with the implanted pulse generator (IPG) turned off for at least 30 minutes to allow the after-effects of stimulation to wear off (baseline). Symptoms were measured again with the IPG turned on at a setting that both minimized the average severity of tremor and bradykinesia and minimized side effects. The Kinesia score rated symptom severity (0, normal; 4, most severe) in four categories: tremor, finger tapping speed, finger tapping amplitude, and finger tapping rhythm. Scores for the four motor symptoms were averaged and converted to percent change from baseline.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Clinical diagnosis of idiopathic Parkinson's disease
  • Implanted deep brain stimulation system awaiting initial programming session

Exclusion Criteria:

  • Subjects with significant psychiatric illness or dementia
  • Significant cognitive impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02046863

Layout table for location information
United States, Ohio
University of Cincinnati Department of Neurology
Cincinnati, Ohio, United States, 45267
Sponsors and Collaborators
Great Lakes NeuroTechnologies Inc.
National Institute of Neurological Disorders and Stroke (NINDS)
University of Cincinnati
Layout table for investigator information
Principal Investigator: Dustin A Heldman, PhD Great Lakes NeuroTechnologies

Publications of Results:
Layout table for additonal information
Responsible Party: Great Lakes NeuroTechnologies Inc. Identifier: NCT02046863     History of Changes
Other Study ID Numbers: 1R43NS081902-01 ( U.S. NIH Grant/Contract )
1R43NS081902 ( U.S. NIH Grant/Contract )
First Posted: January 28, 2014    Key Record Dates
Results First Posted: August 9, 2016
Last Update Posted: September 22, 2016
Last Verified: August 2016
Keywords provided by Great Lakes NeuroTechnologies Inc.:
Parkinson's disease
Deep brain stimulation
Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Neurologic Manifestations
Signs and Symptoms